Stock UniverseDerived research view · source repositories remain read-only

BioCryst Pharmaceuticals, Inc. (BCRX)

Therapeutics / Biopharma · Healthcare / Drug Manufacturers - Specialty & Generic
Score Band
Watch
Selection Score
32.15
Global Rank
1647
Market Cap
2.19B
Latest Close
8.41
RS Composite
-3.61% · G#1641

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-4.76%
3M
-0.83%
6M
7.13%
1Y
-23.82%
3Y
1.69%
5Y
-46.67%
10Y
148.08%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 2.50M · 30-day average: 4.48M · Max drawdown over stored range: -83.64%

Research Snapshot

Relative Strength vs SPX

RS Composite-3.61%
20D RS-6.14%
60D RS-9.91%
120D RS3.95%
Global RS Rank1641 · 51.09% percentile
Watch+Speculative RS Rank1049 · 49.98% percentile
Group ScopeWatch+Speculative
Primary RS Rank159 · 65.28% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank203 / 701
Primary Percentile71.18
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-06n/an/a-381.84M-457.98M-2.03299.36M3.19M296.17M225Mn/an/an/an/an/a238.40M395.20M

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-2.03-4.1xn/an/a$1.316.4x$1.336.3x

Shares Diluted: 225M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue17.812157.17270.827331.412450.712874.837
Revenue Growth (YoY)-63.526%782.383%72.315%22.37%35.997%94.101%
Gross Profit-106.828-58.90210.936114.759264.79689.636
Operating Income-169.731-177.72-148.435-98.781-1.279340.989
Free Cash Flow-135.622-144.542-163.201-97.309-53.144344.901
Free Cash Flow Per Share-0.811-0.807-0.878-0.506-0.2571.577909333382133
EPS (Diluted) GAAP-1.092947-1.027607-1.33-1.18-0.4300081.21
EPS Growth
EPS Non-GAAP
Gross Margin9700%-37.477%4.038%34.627%58.749%78.83%
Operating Margin-952.903%-113.075%-54.808%-29.806%-0.284%38.977%
Profit Margin-1026.353%-117.11%-91.245%-68.356%-19.72%30.161%
Free Cash Flow Margin-761.408%-91.965%-60.26%-29.362%-11.791%39.4246%
Shares Outstanding (Diluted)167.267179.117185.908192.198206.696218.581
Shares Change (YoY)44.695%7.084%3.791%3.383%7.543%5.75%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-061.20Mn/a-701.60M-585.15%-721.81M-602.01%-2.98242.26M238.40M395.20Mprocessed
2025 Q42026-02-26n/an/a260.38Mn/a245.84Mn/a1.12219.28M274.75M314.87Mprocessed
2025 Q32025-11-04n/an/a29.59Mn/a12.90Mn/a0.06219.88M212.87M194.37Mprocessed
2025 Q22025-08-05n/an/a29.79Mn/a5.08Mn/a0.02219.89M260.04M242.79Mprocessed
2025 Q12025-05-06n/an/a21.23Mn/a32.00Kn/a0.00215.26M295.09M315.41Mprocessed
2024 Q42025-02-25n/an/a-4.51Mn/a-26.80Mn/a-0.13207.39M104.71M314.87Mprocessed
2024 Q32024-11-05n/an/a7.69Mn/a-14.03Mn/a-0.07206.91M96.84M314.33Mprocessed
2024 Q22024-08-06n/an/a8.76Mn/a-12.67Mn/a-0.06206.43M78.41M313.82Mprocessed
2024 Q12024-05-07n/an/a-14.49Mn/a-35.38Mn/a-0.17206.06M84.33M308.48Mprocessed
2023 Q42024-02-27n/an/a-42.67Mn/a-61.73Mn/a-0.31201.51M110.64M303.23Mprocessed
2023 Q32023-11-08n/an/a-11.92Mn/a-36.15Mn/a-0.19189.64M150.91M298.00Mprocessed
2023 Q22023-08-07n/an/a-20.70Mn/a-75.33Mn/a-0.40189.12M146.22M293.18Mprocessed
2023 Q12023-05-08n/an/a-28.41Mn/a-53.33Mn/a-0.28188.51M155.14M232.52Mprocessed
2022 Q42023-02-27n/an/a-46.31Mn/a-71.54Mn/a-0.38186.93M304.77M231.62Mprocessed
2022 Q32022-11-04n/an/a-17.45Mn/a-42.52Mn/a-0.23186.18M246.90M223.87Mprocessed
2022 Q22022-08-05n/an/a-34.72Mn/a-58.86Mn/a-0.32185.60M272.57M144.52Mprocessed
2022 Q12022-05-09n/an/a-49.96Mn/a-74.20Mn/an/a184.90M395.50M140.24Mprocessed
2021 Q42022-02-28n/an/a-52.18Mn/a-17.78Mn/a-0.02715.93M504.39M136.08Mprocessed
2021 Q32021-11-04n/an/a-44.58Mn/a-58.80Mn/an/a179.11K199.60M132.05Mprocessed
2021 Q22021-08-09n/an/a-29.58Mn/a-43.20Mn/an/a178.13K210.31M126.80Mprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.